HR17031

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HR17031, covering 2023-04-25 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes [Phase 3]